Changes to This Summary (12/05/2008)
The PDQ cancer information summaries are reviewed regularly and updated as
new information becomes available. This section describes the latest
changes made to this summary as of the date above.
General Information
Added text to state that preparations from mistletoe extracts are most frequently used in the treatment of cancer patients in German-speaking countries (cited Horneber et al. as reference 72).
Human/Clinical Studies
Added text about a study that showed perioperative use of Isorel in the digestive tract of cancer patients, which resulted in an increase in lymphocytes through 14 days of drug administration (cited Enesel et al. as reference 46).
Added text about a nonrandomized Isorel trial to Table 4.
Back to Top
< Previous Section | Next Section > |